Cargando…
Pediatric meningococcocal meningitis in the acute phase: how much does it cost?
BACKGROUND: Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM. METHODS: We calculate the costs for the hospitalization of pediatric patient...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373101/ https://www.ncbi.nlm.nih.gov/pubmed/30760306 http://dx.doi.org/10.1186/s13052-019-0616-z |
_version_ | 1783394904926322688 |
---|---|
author | Bozzola, Elena Guolo, Stefano Bonci, Enea Rossetti, Chiara Bozzola, Mauro Raponi, Massimiliano Villani, Alberto |
author_facet | Bozzola, Elena Guolo, Stefano Bonci, Enea Rossetti, Chiara Bozzola, Mauro Raponi, Massimiliano Villani, Alberto |
author_sort | Bozzola, Elena |
collection | PubMed |
description | BACKGROUND: Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM. METHODS: We calculate the costs for the hospitalization of pediatric patients affected by MM in the acute phase (HAP) over a nine year period. We performed a MEDLINE search to verify the cost of MM HAP reported in other studies. RESULTS: At Bambino Gesù Children Hospital, the median cost of HAP was of 12,604 euro (range from 9203 to 35,050 euro). Comparing our data with the previous studies, we find out similar results of approximately 16,750 euro (range 12,000–20,000 euro). DISCUSSION: Despite the relative rarety of the disease, MM is associated to direct high cost of HAP. CONCLUSIONS: Hospital costs are an important end-point in health economic evaluation of the disease and may be useful to policy makers and health economists to understand the potential benefit of improving meningococcal vaccination programmes. |
format | Online Article Text |
id | pubmed-6373101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63731012019-02-25 Pediatric meningococcocal meningitis in the acute phase: how much does it cost? Bozzola, Elena Guolo, Stefano Bonci, Enea Rossetti, Chiara Bozzola, Mauro Raponi, Massimiliano Villani, Alberto Ital J Pediatr Research BACKGROUND: Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM. METHODS: We calculate the costs for the hospitalization of pediatric patients affected by MM in the acute phase (HAP) over a nine year period. We performed a MEDLINE search to verify the cost of MM HAP reported in other studies. RESULTS: At Bambino Gesù Children Hospital, the median cost of HAP was of 12,604 euro (range from 9203 to 35,050 euro). Comparing our data with the previous studies, we find out similar results of approximately 16,750 euro (range 12,000–20,000 euro). DISCUSSION: Despite the relative rarety of the disease, MM is associated to direct high cost of HAP. CONCLUSIONS: Hospital costs are an important end-point in health economic evaluation of the disease and may be useful to policy makers and health economists to understand the potential benefit of improving meningococcal vaccination programmes. BioMed Central 2019-02-13 /pmc/articles/PMC6373101/ /pubmed/30760306 http://dx.doi.org/10.1186/s13052-019-0616-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Bozzola, Elena Guolo, Stefano Bonci, Enea Rossetti, Chiara Bozzola, Mauro Raponi, Massimiliano Villani, Alberto Pediatric meningococcocal meningitis in the acute phase: how much does it cost? |
title | Pediatric meningococcocal meningitis in the acute phase: how much does it cost? |
title_full | Pediatric meningococcocal meningitis in the acute phase: how much does it cost? |
title_fullStr | Pediatric meningococcocal meningitis in the acute phase: how much does it cost? |
title_full_unstemmed | Pediatric meningococcocal meningitis in the acute phase: how much does it cost? |
title_short | Pediatric meningococcocal meningitis in the acute phase: how much does it cost? |
title_sort | pediatric meningococcocal meningitis in the acute phase: how much does it cost? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373101/ https://www.ncbi.nlm.nih.gov/pubmed/30760306 http://dx.doi.org/10.1186/s13052-019-0616-z |
work_keys_str_mv | AT bozzolaelena pediatricmeningococcocalmeningitisintheacutephasehowmuchdoesitcost AT guolostefano pediatricmeningococcocalmeningitisintheacutephasehowmuchdoesitcost AT boncienea pediatricmeningococcocalmeningitisintheacutephasehowmuchdoesitcost AT rossettichiara pediatricmeningococcocalmeningitisintheacutephasehowmuchdoesitcost AT bozzolamauro pediatricmeningococcocalmeningitisintheacutephasehowmuchdoesitcost AT raponimassimiliano pediatricmeningococcocalmeningitisintheacutephasehowmuchdoesitcost AT villanialberto pediatricmeningococcocalmeningitisintheacutephasehowmuchdoesitcost |